GP KFPs / SAQs · metabolic-and-endocrine-health
Type 2 diabetes — KFP-style written assessment
KFP-style staged scenarios on type 2 diabetes in general practice: confirming diagnosis, comorbidity-driven second-agent selection, the hyperosmolar emergency, insulin initiation, and the remission conversation.
On this page
Study tools
Target exams
RACGP KFPRACGP AKTMRCGP AKT
Prompt
Type 2 diabetes: comorbidity before the number — diagnosis, escalation, emergencies and remission
KFP 1 (10 marks)
A 57-year-old man with BMI 32 kg/m² and hypertension was found on two occasions to have HbA1c 55 mmol/mol (7.2%) and fasting glucose 7.8 mmol/L. He is asymptomatic, walks daily, and asks whether he can "just watch his diet". His father lost a leg to diabetes. [1]
- Confirm or refute the diagnosis with the criteria you would apply, and state what his single-test status would have required had only one result been abnormal. (3) [1]
- Justify starting metformin now rather than diet alone, citing the specific trial evidence. (4) [2]
- Outline the annual complication surveillance you will schedule from today. (3) [3]
Model answers
- The diagnosis is confirmed: HbA1c 55 mmol/mol exceeds the 48 mmol/mol (6.5%) threshold and fasting glucose 7.8 mmol/L exceeds 7.0 mmol/L — two abnormal results from the same or separate samples suffice in an asymptomatic patient. Had only one test been abnormal, confirmation with a second abnormal result (repeat HbA1c, fasting glucose or OGTT) would be required before labelling. [1]
- UKPDS 34 randomised overweight patients with newly diagnosed type 2 diabetes to metformin or conventional diet therapy over a median 10.7 years: metformin reduced any diabetes-related endpoint by 32% (95% CI 13–47), diabetes-related death by 42%, and all-cause mortality by 36% — benefits diet alone did not deliver. His family history of diabetic complications strengthens the case for immediate pharmacotherapy alongside lifestyle change. [2]
- Annual cycle: dilated retinal photography; urine albumin-to-creatinine ratio and eGFR; foot examination with 10 g monofilament and pulse assessment; blood pressure, lipids, weight and smoking review; influenza and pneumococcal vaccination status; and structured hypoglycaemia/driving advice whenever regimens change. [3]
References7ShowHide
- [1]American Diabetes Association Professional Practice Committee 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2025 Diabetes Care, 2025.PMID 39651986
- [2]UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet, 1998.PMID 9742977
- [3]Davies MJ, Aroda VR, Collins BS, et al. Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association and the European Association for the Study of Diabetes Diabetologia, 2022.PMID 36151309
- [4]Perkovic V, Jardine MJ, Neal B, et al. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy N Engl J Med, 2019.PMID 30990260
- [5]Pasquel FJ, Umpierrez GE Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment Diabetes Care, 2014.PMID 25342831
- [6]Lean MEJ, Leslie WS, Barnes AC, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial Lancet, 2018.PMID 29221645
- [7]Lasserson DS, Glasziou P, Perera R, et al. Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses Diabetologia, 2009.PMID 19644668